Skip to main content
. 2021 Oct 30;27(4):453–481. doi: 10.5056/jnm21077
  • Statement 20: Proton pump inhibitor therapy is recommended to treat non-cardiac chest pain in patients with concomitant typical gastroesophageal reflux disease symptoms.

  •      Level of evidence: moderate

  •      Strength of recommendation: strong

  •      Experts’ opinions: agree strongly (46.7%), agree with some reservations (51.1%), undecided (2.2%), disagree (0.0%), and disagree strongly (0.0%)